Summit Therapeutics (NASDAQ:SMMT) Shares Up 10.6%

Summit Therapeutics Inc. (NASDAQ:SMMT – Get Free Report)’s stock price shot up 10.6% on Tuesday . The stock traded as high as $3.86 and last traded at $3.86. 399,225 shares were traded during mid-day trading, a decline of 82% from the average session volume of 2,188,287 shares. The stock had previously closed at $3.49. Analysts […]

Related Keywords

United States ,United Kingdom ,Ankur Dhingra ,Mahkam Zanganeh ,Stifel Nicolaus ,Zurcher Kantonalbank Zurich Cantonalbank ,Summit Therapeutics Inc ,Nasdaq ,Wealth Management Partners ,Summit Therapeutics Company Profile ,Tower Research Capital ,Securities Exchange Commission ,Aristides Capital ,Sectoral Asset Management Inc ,Summit Therapeutics ,Get Free Report ,Exchange Commission ,Management Partners ,Asset Management ,Research Capital ,Kantonalbank Zurich Cantonalbank ,Therapeutics Inc ,Summit Therapeutics Daily ,